Loading insider details...
Beta
Latest Form 4 (Aug 3, 2026): Disposition to Issuer of 51,890 APMD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 3, 2026 | Apnimed, Inc. (APMD) | Disposition to Issuer | 51,890 | n/a |
| Jun 8, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 24,372 | n/a |
| May 14, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | Tender of Shares | 30,666 | n/a |
| Jan 5, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/Award | 7,961 | n/a |
| Jun 9, 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 25,000 | n/a |
| Jan 3, 2025 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/Award | 6,267 | n/a |
| Jun 7, 2024 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 25,000 | n/a |
| Jan 2, 2024 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/Award | 3,341 | n/a |
| Jun 12, 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 16,985 | n/a |
| Jan 4, 2023 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/Award | 3,867 | n/a |